Price
621.85
+0.31%52W Range
Market Cap
₹2,436.79 Cr
Traded: ₹9.97 Cr (0.41%) 0.0x
Free Float: ₹525.13 Cr (1.90% of FF traded)
Volume · 60D trend
1.62 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -- | +16.0% | +13.0% | -- | -- | Decelerating |
| Return | -- | -- | -- | +15.0% | -- | -- |
| Profit | -- | +24.0% | +7.0% | -- | +16.0% | Stable |
| Sales | -- | +18.0% | +8.0% | -- | +24.0% | Stable |
Quarterly Results
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 316 | 286 | 248 | 220 | 218 | 224 | 209 | 212 | 203 | 181 | 161 | 153 | 172 | 194 |
| Expenses | 282 | 265 | 226 | 202 | 198 | 205 | 186 | 191 | 180 | 164 | 147 | 145 | 167 | 179 |
| Operating Profit | 34 | 21 | 23 | 18 | 20 | 19 | 23 | 21 | 22 | 17 | 15 | 8 | 5 | 16 |
| OPM % | 11.0% | 8.0% | 9.0% | 8.0% | 9.0% | 9.0% | 11.0% | 10.0% | 11.0% | 9.0% | 9.0% | 5.0% | 3.2% | 8.0% |
| Other Income | 3 | 5 | 3 | 4 | 3 | 4 | 3 | 3 | 0 | 3 | 2 | -1 | 2 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 35 | 25 | 25 | 20 | 22 | 22 | 24 | 23 | 21 | 18 | 15 | 5 | 5 | 16 |
| Tax % | 25.0% | 26.0% | 25.0% | 26.0% | 25.0% | 26.0% | 26.0% | 26.0% | 25.0% | 25.0% | 28.0% | 22.0% | 25.0% | 27.0% |
| Net Profit | 26 | 19 | 18 | 15 | 16 | 16 | 18 | 17 | 16 | 14 | 11 | 4 | 4 | 12 |
| Exceptional Items | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 |
| EPS (Rs) | 6.4 | 4.7 | 4.5 | 3.7 | 4.0 | 3.9 | 4.3 | 4.2 | 3.9 | 3.3 | 3.2 | 1.2 | 1.2 | 3.6 |
| Sales Growth (YoY) | 45.0% | 27.7% | 18.7% | 3.8% | 7.4% | 23.8% | 29.8% | 38.6% | 18.0% | -6.7% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 10.5% | 15.3% | 12.7% | 0.9% | -2.7% | 7.2% | -1.4% | 4.4% | 12.2% | 12.4% | 5.2% | -11.1% | -11.3% | -- |
| OP Growth (YoY) | 70.0% | 10.5% | 0.0% | -14.3% | -9.1% | 11.8% | 53.3% | 162.5% | 340.0% | 6.3% | -- | -- | -- | -- |
| OP Growth (QoQ) | 61.9% | -8.7% | 27.8% | -10.0% | 5.3% | -17.4% | 9.5% | -4.5% | 29.4% | 13.3% | 87.5% | 60.0% | -68.8% | -- |
| Profit Growth (YoY) | -- | 18.6% | 3.1% | -12.8% | 3.8% | 17.3% | 66.0% | 231.2% | 300.0% | 15.7% | -- | -- | -- | -- |
| EPS Growth (YoY) | 59.2% | 18.6% | 3.2% | -12.8% | 3.6% | 17.4% | 34.5% | 256.8% | 223.3% | -6.4% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 37.6% | 4.0% | 21.8% | -8.7% | 2.5% | -9.5% | 2.9% | 8.5% | 16.2% | 3.7% | 172.9% | -1.7% | -66.4% | -- |
| OP Margin | 10.8% | 7.3% | 9.3% | 8.2% | 9.2% | 8.5% | 11.0% | 9.9% | 10.8% | 9.4% | 9.3% | 5.2% | 2.9% | 8.3% |
| Net Margin | 8.2% | 6.6% | 7.3% | 6.8% | 7.3% | 7.1% | 8.6% | 8.0% | 7.9% | 7.7% | 6.8% | 2.6% | 2.3% | 6.2% |
| Material Cost % | -- | 84.0% | 81.0% | 82.0% | 82.0% | 82.0% | 78.0% | 79.0% | 79.0% | 80.0% | 79.0% | 84.0% | 87.0% | 82.0% |
| Employee Cost % | -- | 2.0% | 3.0% | 2.0% | 2.0% | 2.0% | 2.0% | 2.0% | 2.0% | 2.0% | 3.0% | 3.0% | 2.0% | 2.0% |
| P/S | 2.28 | 2.23 | 1.79 | 1.63 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 32.40 | 32.89 | 25.88 | 22.69 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 4.62 | 4.10 | 3.31 | 2.88 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Intimation of material event under Regulation 30(3) and 30(9) of SEBI (LODR) Regulations, 2015- Acquisition of land
Earnings Call Transcript for Q1 Financial performance which held on 10th August,2026
Intimation for Schedule of Analyst or Investor meet on 13th August,2026
Intimation for Schedule of Analyst or Investor Meet on 14th August, 2026
Audio Recordings of Call held on 10th August 2026
Newspaper Publication
Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended 30th June, 2026
Monitoring Agency Report for the Quarter ended 30th June, 2026
Earnings Presentation for the Quarter ended 30th June, 2026
Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2026
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Closure of Trading Window for the quarter ending 30th June 2026
Intimation of Schedule of Analyst/Institutional Investors Meeting
Intimation of Schedule of Analyst/Institutional Investors Meeting
Transcript of Earnings Conference Call for Financial Performance for the 4th Quarter and Year ended March 31, 2026
EARNINGS CALL FOR QUARTER AND YEAR ENDED 31ST MARCH 2026
NEWSPAPER PUBLICATION DATED 16052026
Analyst/Investor Meet on 20th May,2026
MONITORING AGENCY REPORT 31ST MARCH FY26
Audited Financial Statements for the year ended 31.03.2026
Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31.03.2026
Earnings Presentation for Q4 FY26
MONITORING AHENCY REPORT FOR THE YEAR ENDED 31ST MARCH 2026
J.G.Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve The Audited Financial Results ....
Investor Meet Intimation dated 15th May 2026
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st March, 2026
CLOSURE OF TRADING WINDOW FOR THE QUARTER AND YEAR ENDED 31ST MARCH 2026
Intimation of Schedule of Analyst/Institutional Investors Meeting dated 24.03.2026
Intimation regarding Investor Meet on 9th march 2026
Earnings Call Transcript for Q3 F.Y. 2026
Audio Recordings of Investors Earning call for the Q3 FY26
Newspaper Publication of Unaudited Standalone and Consolidated Financial Results for the quarter ended 31.12.2025
Earnings Presentation Q3 2025-2026
Earnings Presentation Q3 2025-2026
Submission of Monitoring Agency Report for the quarter ended 31st December, 2025
Unaudited Financial Standalone and Consolidated Results for the quarter ended 31.12.2025
Outcome of Board Meeting dated 14th February 2026
Intimation of Q3 (FY 25-26) Post Result Conference Call
J.G.Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Quarterly Unaudited Results for ....
Compliance under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.12.2025
Closure of Trading Window for the quarter ended 31.12.2025
Intimation of Schedule of Analyst/Institutional Investor Meeting
Intimation of Schedule of Analyst/Institutional Investor(s) Meeting
Earnings Call Transcript Q2 FY26
JGCL-Earnings_Call_Audio_Q2 FY 2026
Newspaper Publication of Unaudited Financial Results for the Quarter and half year ended 30th September 2025
Monitoring Agency Report 30th September 2025
EARNINGS PRESENTATION OF Q2 FY25-26
EARNINGS PRESENTATION OF Q2 FY25-26
Approval for the Unaudited Financial Results for the Quarter & Half-year ended on 30th September, 2025
Credit Ratings
3Concalls
11Feb 2026
28 Feb 2026Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Jul 2024
31 Jul 2024May 2024
31 May 2024